The international liquid biopsy sector is seeing significant increase, driven by advancements in tumor diagnosis and precision medicine. Current projections value the market revenue at approximately USD X.X billion dollars in 2024, with predictions indicating a compound annual rate of Y% through 2032. Key trends feature the growing usage of minimal